Session » Metabolic and Crystal Arthropathies Poster I

Date: Sunday, November 8, 2015

Time: 9:00AM-11:00AM

Meeting: 2015 ACR/ARHP Annual Meeting

9:00AM-11:00AM: Abstract Number: 220

A Genome-Wide Association Study Reveals Association of the Transferrin Receptor Locus with Gout

9:00AM-11:00AM: Abstract Number: 213

A Method for Counting Monosodium Urate Crystals in the Synovial Fluid of Gout Patients

9:00AM-11:00AM: Abstract Number: 214

Basic Calcium Phosphate Crystal Interactions with Tenocytes: An in Vitro Model of Calcific Tendinitis

9:00AM-11:00AM: Abstract Number: 215

Calcium Hydroxyapatite Crystals Inhibit Interleukin-6- and Interferon-γ –Induced Anti-Osteoclastogenic Signaling in Human Osteoclast Precursors

9:00AM-11:00AM: Abstract Number: 217

Circulating Levels of Neo-Epitopes Reflecting Connective Tissue Turnover As Biomarkers of Gout and Frequent Gout Attacks in Men

9:00AM-11:00AM: Abstract Number: 221

Clinical and Genetic Characteristics of Diuretic-Associated Gout: A Case-Control Study

9:00AM-11:00AM: Abstract Number: 218

Diet-Wide Association Study of Serum Urate Levels in 13,782 Individuals of European Ancestry

9:00AM-11:00AM: Abstract Number: 216

Effects of Monosodium Urate Crystals on Mlo-Y4 Cell Viability; Is There a Role for Osteocytes in Erosive Gout?

9:00AM-11:00AM: Abstract Number: 236

Foot and Ankle Muscle Strength in People with Gout: A Two-Arm Cross-Sectional Study

9:00AM-11:00AM: Abstract Number: 228

Gout and Risk of Non-Vertebral Osteoporotic Fracture

9:00AM-11:00AM: Abstract Number: 233

Gout Does Not Decrease the Risk of Parkinson’s Disease: A Systematic Review and Meta-Analysis

9:00AM-11:00AM: Abstract Number: 225

Gout Patients Present Carotid Plaques at Presentation in Spite of Low-Risk Cardiovascular Score

9:00AM-11:00AM: Abstract Number: 242

Higher Serum Uric Acid Levels Are Associated with an Increased Risk of Flares: A Systematic Review

9:00AM-11:00AM: Abstract Number: 244

Hospitalization and Flare Risk in Patients with Established Gout: A Population-Based Study

9:00AM-11:00AM: Abstract Number: 232

Hyperuricemia, Urate Lowering Therapy and Kidney Function: A Systemic Review and Meta-Analysis

9:00AM-11:00AM: Abstract Number: 227

Impact of Gout on the Risk of Atrial Fibrillation

9:00AM-11:00AM: Abstract Number: 243

Increase in Risk of Future Attacks in Patients with Incident Gout: A Population-Based Study over 20 Years

9:00AM-11:00AM: Abstract Number: 223

Increased Platelet Reactivity in Gout: A Potential Mechanism for Adverse Cardiovascular Events

9:00AM-11:00AM: Abstract Number: 241

Inflammatory Syndrome in Polyarticular Gout – Description of a Previously Neglected Entity

9:00AM-11:00AM: Abstract Number: 226

Prevalence of Cardiovascular Disease in Patients with Gout, Osteoarthritis or Both

9:00AM-11:00AM: Abstract Number: 235

Relationship Between Tissue Stress during Gait and Patterns of Urate Deposition and Bone Erosion in Gout: A Biomechanical Computational Modelling Study

9:00AM-11:00AM: Abstract Number: 238

Relationship Between Ultrasonographic Synovial Inflammation and Ultrasonographic Urate Deposition Findings in Patients with Gout

9:00AM-11:00AM: Abstract Number: 212

Rising Incidence and Prevalence of Gout in the Canadian General Population

9:00AM-11:00AM: Abstract Number: 245

Seasonal Variation in Acute Gouty Arthritis: Data from Nationwide Inpatient Sample

9:00AM-11:00AM: Abstract Number: 222

Serum Delta Neutrophil Index Measurement for Differentiating Acute Gouty Arthritis and Cellulitis in Normouricemic Patients

9:00AM-11:00AM: Abstract Number: 230

Serum Uric Acid As Short Term Mortality Predictor in the Acute Care Setting

9:00AM-11:00AM: Abstract Number: 224

Silent Monosodium Urate Crystals Deposits in Asymptomatic Hyperuricemia Lead to a Higher Need for Coronary Revascularization

9:00AM-11:00AM: Abstract Number: 219

Targeted Deep Resequencing Identifies MRP4/ABCC4 as a Gout Risk Locus in the New Zealand Mä�ori and Pacific Island Populations

9:00AM-11:00AM: Abstract Number: 211

The Epidemiology of Gout: Marked Increase in Incidence and Comorbidities over 20 Years

9:00AM-11:00AM: Abstract Number: 237

The Prevalence of Chondrocalcinosis of the Symphysis Pubis on CT Scan and Correlation with Calcium Pyrophosphate Dihydrate Crystal Deposition Disease

9:00AM-11:00AM: Abstract Number: 239

The Role of Dual Energy Computed Tomography in Diagnosing Acute Gouty Arthritis: Comparison with Ultrasound and Aspiration

9:00AM-11:00AM: Abstract Number: 229

Uric Acid and Incident Dementia over 10 Years

9:00AM-11:00AM: Abstract Number: 231

Uric Acid Levels Predict Mortality in Women

9:00AM-11:00AM: Abstract Number: 240

Volumetric Assessment of Tophaceous Gout

9:00AM-11:00AM: Abstract Number: 234

Weight Variables and Their Association with Serum Urate Concentrations and Hyperuricemia in Young Adults

« View all sessions from this meeting

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].